Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells
暂无分享,去创建一个
[1] Xin Hu,et al. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells. , 2005, Cancer research.
[2] D. Welch,et al. Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment , 2005, Breast Cancer Research.
[3] Xin Hu,et al. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo. , 2004, International journal of oncology.
[4] E. Gerner,et al. Polyamines and cancer: old molecules, new understanding , 2004, Nature Reviews Cancer.
[5] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[6] D. Kramer,et al. The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. , 2003, Cancer research.
[7] Paul J. Williams,et al. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.
[8] L. Pfeffer,et al. Inhibition of ornithine decarboxylase induces STAT3 tyrosine phosphorylation and DNA binding in IEC-6 cells. , 2000, American journal of physiology. Cell physiology.
[9] J. Díaz,et al. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] T. Martin,et al. A novel orthotopic model of breast cancer metastasis to bone , 1999, Clinical & Experimental Metastasis.
[11] T. Patel,et al. Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. , 1999, The American journal of physiology.
[12] P. Gimotty,et al. Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] J. Darnell,et al. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.
[14] F. Miller,et al. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.
[15] N. Seiler,et al. Endogenous and exogenous polyamines in support of tumor growth. , 1990, Cancer research.
[16] L. Persson,et al. Increased formation of N1-acetylspermidine in human breast cancer. , 1989, Cancer letters.
[17] A. Pegg,et al. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.
[18] Xin Hu,et al. Effects of Polyamine Synthesis Inhibitors on Primary Tumor Features and Metastatic Capacity of Human Breast Cancer Cells , 2005, Clinical & Experimental Metastasis.
[19] G. Matters,et al. Inhibitors of Polyamine Biosynthesis Decrease the Expression of the Metalloproteases Meprin α and MMP-7 in Hormone-independent Human Breast Cancer Cells , 2005, Clinical & Experimental Metastasis.
[20] A. Manni,et al. Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells , 2004, Clinical & Experimental Metastasis.
[21] D. Welch,et al. Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells , 2004, Clinical & Experimental Metastasis.
[22] D. Welch,et al. Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. , 2003, Clinical & experimental metastasis.
[23] A. Manni. Role of the Polyamine Pathway in the Natural History of Breast Cancer , 1999 .